← FDA Drug Approvals (Drugs@FDA)

LITHIUM CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SCIEGEN PHARMS · Approved 2024-03-18

Drug application

FDA Application #

ANDA217183

Application type

Abbreviated New Drug Application (Generic)

Brand name

LITHIUM CITRATE

Generic name

LITHIUM

Active ingredients

LITHIUM CITRATE

Dosage form

SYRUP

Route

ORAL

Marketing status

Prescription

Sponsor

SCIEGEN PHARMS

Manufacturer

Saptalis Pharmaceuticals, LLC

First approval

2024-03-18

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown